FirmaIQ
Org.nr 994 297 422 2023 → 2024 Year-over-year analysis

THOR MEDICAL ASA: årsregnskap 2024 vs 2023

Weaker earnings

approved 2025-04-24; registry 2025-08-09; journal 2025 681223

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2024 with 2023 for THOR MEDICAL ASA. Revenue 0 NOK → 0 NOK (0.0%). Net result -2.85m NOK → -40.59m NOK. Equity 274.63m NOK → 341.5k NOK.

On the constructive side: cash rose. Pressures included: operating result weakened; net result weakened; equity eroded.

Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for THOR MEDICAL ASA.

At a glance

Scorecard

Revenue
0 NOK 0 NOK
0.0%
Operating result
-4.36m NOK -41.95m NOK
-862.9%
Net result
-2.85m NOK -40.59m NOK
-1321.8%
Equity
274.63m NOK 341.5k NOK
-99.9%
Cash
40.42m NOK 122.56m NOK
+203.2%
Total assets
278.41m NOK 363.9k NOK
-99.9%

What improved

  • ↑

    Cash rose

    Bank deposits 40.42m NOK → 122.56m NOK (+203.2% YoY). Calculated

What deteriorated

  • ↓

    Operating result weakened

    Operating result -4.36m NOK → -41.95m NOK. Calculated

  • ↓

    Net result weakened

    Net result -2.85m NOK → -40.59m NOK. Calculated

  • ↓

    Equity eroded

    Book equity 274.63m NOK → 341.5k NOK (equity ratio 98.6% → 93.8%). Calculated

Things to notice

  • ·

    Paid-in equity reduced

    Paid-in equity fell 292.78m NOK → 400.2k NOK — check capital reduction, conversion, or reclassification. Interpretation

  • ·

    Book investments changed

    Investment / intangible book value 234.7k NOK → 234.71m NOK. Reported fact